Evaluating the utility of ambulatory blood pressure monitoring in kidney transplant recipients

Clinical Transplantation

Volumn 26, Issue 5, 2012, Pages

  Wen, Kevin C ^a   Gourishankar, Sita ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Ambulatory blood pressure monitoring; Blood pressure; Hypertension; Kidney transplant

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ACCURACY; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; DIASTOLIC BLOOD PRESSURE; FEMALE; GRAFT RECIPIENT; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 84867583914     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12009.     Document Type: Article

References (23)

1. Tomson CRV. Cardiovascular complications after renal transplantation. In: Morris PJ, ed. Kidney Transplantation. Philadelphia, PA: WB Saunders, 2001: 445.
2. Opelz G, Wujciak T, Ritz E. Association of chornic kidney graft failure with recipient blood pressure: Collaborative Transplant Study. Kidney Int 1998: 53: 217.
3. Cosio FG, Pelletier RP, Sedmak DD, Pesavento TE, Henry ML, Ferguson RM. Renal allograft survival following acute rejection correlates with blood pressure levels and histopathology. Kidney Int 1999: 56: 1912.
4. Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft. JAMA 2000: 283: 633.
5. Fernandez-Fresnedo G, Palomar R, Escallade R et al. Hypertension and long-term renal allograft survival: effect of early glomerular filtration rate. Nephrol Dial Transplant 2001: 16(Suppl 1): 105.
6. Thompson AM, Pickering TG. The role of ambulatory blood pressure monitoring in chronic and end-stage renal disease. Kidney Int 2006: 70: 1000.
7. Sega R, Facchetti R, Bombelli M et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose monitorate e Loro Associazioni (PAMELA) study. Circulation 2005: 111: 1777.
8. Zaninelli A, Parati G, Cricelli C et al. Office and 24-h ambulatory blood pressure control by treatment in general practice: the 'Monitoraggio della pressione arteriosa nella medicina Territoriale' study. J Hypertens 2010: 28: 1.
9. Kanno A, Metoki H, Kikuya M et al. Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease: the Ohasama study. Hypertens Res 2010: 33: 1192.
10. Palatini P. Ambulatory blood pressure and cardiovascular risk in chronic kidney disease. Curr Hyptertens Rep 2008: 10: 119.
11. Ferraris JR, Ghezzi L, Waisman G, Krmar RT. ABPM vs office blood pressure to define blood pressure control in treated hypertensive paediatric renal transplant recipients. Pediatr Transplant 2007: 11: 24.
12. Kooman JP, Christiaans MH, Boots JM, van Der Sande FM, Leunissen KM, van Hooff JP. A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy. Am J Kidney Dis 2001: 37: 1170.
13. Stenehjem AE, Gudmundsdottir H, Os I. Office blood pressure measurements overestimate blood pressure control in renal transplant patients. Blood Press Monit 2006: 11: 125.
14. Paoletti E, Gherzi M, Amidone M, Massarino F, Cannella G. Association of arterial hypertension with renal target organ damage in kidney transplant recipients: the predictive role of ambulatory blood pressure monitoring. Transplantation 2009: 87: 1864.
15. Haydar AA, Covic A, Jayawardene S et al. Insights from ambulatory blood pressure monitoring: diagnosis of hypertension and diurnal blood pressure in renal transplant recipients. Transplantation 2004: 77: 849.
16. Haydar AA, Covic A, Agharazii M, Jayawardene S, Taylor J, Goldsmith DJ. Systloic blood pressure diurnal variation is not a predictor of renal target organ damage in kidney transplant recipients. Am J Transplant 2004: 4: 244.
17. Hypertension Canada. Canadian Hypertension Education Program. 2011. http://hypertension.ca/chep/diagnosis-assessment/accurate-measurement-of-blood-pressure/. Accessed April 2011.
18. National Kidney Foundation. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004: 43(Suppl 1): 65.
19. Agena F, Prado EDS, Souza PS et al. Home blood pressure (BP) monitoring in kidney transplant recipients is more adequate to monitor BP than office BP. Nephrol Dial Transplant 2011: 26: 3745.
20. de la Sierra A, Segura J, Gorostidi M, Banegas JR, de la Cruz JJ, Ruilope LM. Diurnal blood pressure variation, risk categories and antihypertensive treatment. Hypertens Res 2010: 33: 767.
21. Tamura K, Yamauchi J, Tsurumi-Ikeya Y et al. Ambulatory blood pressure and heart rate in hypertensives with renal failure: comparison between diabetic nephropathy and non-diabetic glomerulopathy. Clin Exp Hypertens 2008: 30: 33.
22. Liu M, Takahashi H, Morita Y et al. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant 2003: 18: 563.
23. Covic A, Gusbeth-Tatomir P, Mardare N, Buhaescu I, Goldsmith DJ. Dynamics of the circadian blood pressure profiles after renal transplantation. Transplantation 2005: 80: 1168.